Powder: -20°C for 3 years | In solvent: -80°C for 1 year
L-838417 D9 (C-21191) is a novel deuterated subtype-selective GABAA positive allosteric modulator, acting as a partial agonist at α2, α3 and α5 subtypes[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 229.00 | |
5 mg | In stock | $ 485.00 | |
10 mg | In stock | $ 693.00 | |
25 mg | In stock | $ 1,090.00 | |
50 mg | In stock | $ 1,490.00 | |
100 mg | In stock | $ 1,970.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 585.00 |
Description | L-838417 D9 (C-21191) is a novel deuterated subtype-selective GABAA positive allosteric modulator, acting as a partial agonist at α2, α3 and α5 subtypes[1]. |
Synonyms | CTP354, CTP354 (C-21191), C-21191 |
Molecular Weight | 408.45 |
Formula | C19H10D9F2N7O |
CAS No. | 1213669-91-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 12 mg/ml (29.38 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
L-838417 D9 1213669-91-0 Membrane transporter/Ion channel Neuroscience GABA Receptor L-838417 D-9 CTP 354 CTP354 Inhibitor C 21191 CTP354 (C-21191) CTP-354 inhibit L 838417 D9 L838417 D9 C21191 C-21191 inhibitor